Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 51

1.

Efficacy and tolerability of desvenlafaxine succinate treatment for menopausal vasomotor symptoms: a randomized controlled trial.

Speroff L, Gass M, Constantine G, Olivier S; Study 315 Investigators.

Obstet Gynecol. 2008 Jan;111(1):77-87. doi: 10.1097/01.AOG.0000297371.89129.b3.

PMID:
18165395
2.

Main morbidities recorded in the women's international study of long duration oestrogen after menopause (WISDOM): a randomised controlled trial of hormone replacement therapy in postmenopausal women.

Vickers MR, MacLennan AH, Lawton B, Ford D, Martin J, Meredith SK, DeStavola BL, Rose S, Dowell A, Wilkes HC, Darbyshire JH, Meade TW; WISDOM group.

BMJ. 2007 Aug 4;335(7613):239. Epub 2007 Jul 11.

3.

Pilot study of fluvoxamine treatment for climacteric symptoms in Japanese women.

Oishi A, Mochizuki Y, Otsu R, Inaba N.

Biopsychosoc Med. 2007 Jun 5;1:12.

4.

Women's attitudes to hormone replacement therapy, alternative therapy and sexual health: a web-based survey.

Cumming GP, Herald J, Moncur R, Currie H, Lee AJ.

Menopause Int. 2007 Jun;13(2):79-83.

PMID:
17540139
5.

Ineffectiveness of sertraline for treatment of menopausal hot flushes: a randomized controlled trial.

Grady D, Cohen B, Tice J, Kristof M, Olyaie A, Sawaya GF.

Obstet Gynecol. 2007 Apr;109(4):823-30.

PMID:
17400842
6.

Clinical practice. Management of menopausal symptoms.

Grady D.

N Engl J Med. 2006 Nov 30;355(22):2338-47. Review. No abstract available.

7.
8.

Complementary and alternative therapies for the management of menopause-related symptoms: a systematic evidence review.

Nedrow A, Miller J, Walker M, Nygren P, Huffman LH, Nelson HD.

Arch Intern Med. 2006 Jul 24;166(14):1453-65. Review.

PMID:
16864755
9.

Nonhormonal therapies for menopausal hot flashes: systematic review and meta-analysis.

Nelson HD, Vesco KK, Haney E, Fu R, Nedrow A, Miller J, Nicolaidis C, Walker M, Humphrey L.

JAMA. 2006 May 3;295(17):2057-71. Review.

PMID:
16670414
10.

Noradrenergic and serotonergic modulation to treat vasomotor symptoms.

Albertazzi P.

J Br Menopause Soc. 2006 Mar;12(1):7-11. Review.

PMID:
16513016
11.

Paroxetine is an effective treatment for hot flashes: results from a prospective randomized clinical trial.

Stearns V, Slack R, Greep N, Henry-Tilman R, Osborne M, Bunnell C, Ullmer L, Gallagher A, Cullen J, Gehan E, Hayes DF, Isaacs C.

J Clin Oncol. 2005 Oct 1;23(28):6919-30. Erratum in: J Clin Oncol. 2005 Nov 20;23(33):8549.

PMID:
16192581
12.

Citalopram and fluoxetine in the treatment of postmenopausal symptoms: a prospective, randomized, 9-month, placebo-controlled, double-blind study.

Suvanto-Luukkonen E, Koivunen R, Sundström H, Bloigu R, Karjalainen E, Häivä-Mällinen L, Tapanainen JS.

Menopause. 2005 Jan-Feb;12(1):18-26.

PMID:
15668596
13.

The role of complementary and alternative medicine in management of menopausal symptoms.

Kessel B, Kronenberg F.

Endocrinol Metab Clin North Am. 2004 Dec;33(4):717-39. Review.

PMID:
15501642
14.

Soy isoflavones and melatonin for the relief of climacteric symptoms: a multicenter, double-blind, randomized study.

Secreto G, Chiechi LM, Amadori A, Miceli R, Venturelli E, Valerio T, Marubini E.

Maturitas. 2004 Jan 20;47(1):11-20.

PMID:
14706761
15.
16.

Paroxetine controlled release in the treatment of menopausal hot flashes: a randomized controlled trial.

Stearns V, Beebe KL, Iyengar M, Dube E.

JAMA. 2003 Jun 4;289(21):2827-34.

PMID:
12783913
17.

Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmenopausal women: the Women's Health Initiative Memory Study: a randomized controlled trial.

Shumaker SA, Legault C, Rapp SR, Thal L, Wallace RB, Ockene JK, Hendrix SL, Jones BN 3rd, Assaf AR, Jackson RD, Kotchen JM, Wassertheil-Smoller S, Wactawski-Wende J; WHIMS Investigators.

JAMA. 2003 May 28;289(20):2651-62.

PMID:
12771112
18.

Medical choices available for management of menopause.

Farrell E.

Best Pract Res Clin Endocrinol Metab. 2003 Mar;17(1):1-16. Review.

PMID:
12763509
19.
20.

The role of treatment intentions and concerns about side effects in women's decision to discontinue postmenopausal hormone therapy.

Reynolds RF, Obermeyer CM, Walker AM, Guilbert D.

Maturitas. 2002 Nov 20;43(3):183-94.

PMID:
12443835

Supplemental Content

Support Center